Skip to content

Perspective

Frontiers in Transplantation ·

Volume 5 - 2026 | https://doi.org/10.3389/frtra.2026.1880820

Facial transplantation in emerging adulthood: characterizing challenges and opportunities to support optimal outcomes

  • Michael E. McKenna1
  • Hailey P. Wyatt1
  • Alexis K. Gursky1
  • Eduardo D. Rodriguez1
  • Laura L. Kimberly1,2*corresponding author
  1. 1Hansjörg Wyss Department of Plastic Surgery, NYU Grossman School of Medicine, New York, NY, United States
  2. 2Department of Population Health, NYU Grossman School of Medicine, New York, NY, United States
Article metrics0 viewsView details

Abstract

Ethical considerations in facial transplantation have been widely discussed for more than twenty years, preceding the technical realization of the procedure in 2005. With more than 50 face transplants performed to date in adults worldwide, considerations are evolving beyond risks and benefits toward questions of equity and sustainability. Yet, issues of informed consent, the risk of lifelong immunosuppression, graft lifespan, and metrics for success continue to prompt dialogue, especially for certain patient populations. In this Perspective, we combine our clinical experience with a synthesis of the existing evidence and propose that emerging adults, characterized as individuals aged 18–25, be given particular consideration. Emerging adults occupy a middle ground between adolescence and established adulthood. This formative life stage has a profound impact on an individual's sense of identity and social integration. Emerging adults stand to benefit significantly from facial transplantation precisely because of the key developmental nature of this stage, yet ongoing cognitive development presents challenges for judgement and decision-making that can complicate care for this population and impact outcomes. Given the complexity of facial transplantation and lifelong commitment to follow up required for face transplant recipients, it is critical to understand potential challenges for decision-making and obstacles to adherence that individuals may face in this developmental life stage. Recognizing emerging adults as a patient population with specific support needs will enable face transplant programs to offer tailored supports to improve outcomes for this transformative procedure in emerging adulthood.

Keywords

1 Background

Vascularized Composite Allotransplantation (VCA) is the transfer of a functional unit containing multiple tissue types such as skin, muscle, bone, nerves, and blood vessels (1). While hand transplant is the most common form of VCA, face, uterine, penile, abdominal wall, and larynx transplant have also been performed (2). As a type of VCA, facial transplantation (FTx) is significant for its ability to restore recipients' functional capacity and sense of aesthetic normalcy. The procedure's novelty and profound ethical ramifications have led to extensive media attention since its initiation (3–6). The first successful FTx was performed in 2005 by a team in Amiens, France who replaced the central and lower face of a 38 year old-woman with a facial graft from a brain-dead donor (7). As of 2026, more than 50 face transplants have been performed worldwide (8, 9). The indications for FTx are broad. Severe burns, ballistic injury, motor vehicle trauma, animal attacks, and congenital disfigurements may all lead to profound functional and aesthetic deficits which are not amenable to traditional reconstructive techniques and could be ameliorated by FTx (10, 11). Published reports suggest outcomes of the procedure have been largely positive. For the first 50 FTx recipients, 5 and 10-year survival rates were 85 percent and 74 percent, respectively (8), with many recipients of FTx reporting marked improvements in pain, function, mental wellbeing, and overall quality of life (12–14).

The risks and benefits of FTx for the adult population have been widely discussed, emphasizing the technical aspects of the procedure as well as ethical and psychosocial implications (2). Technical research has focused primarily on the consequences of lifelong immunosuppressive medication, the avoidance of rejection events, and emerging surgical technologies (15, 16). Ethical and psychosocial aspects of FTx include weighing risks and benefits and ensuring robust informed consent, addressing equity in access to care among diverse patient populations, respecting patient privacy, and investigations into geographic and financial barriers to care (2). Ethical concerns in pediatric facial transplantation are the subject of ongoing discussion in the field, with a clearly recognized and distinct set of considerations. Technical questions regarding the feasibility of the procedure remain unanswered, and the ethical implications of FTx in this population, such as capacity to provide informed assent and the risks of long-term immunosuppression and graft loss, are particularly pronounced. To date, FTx has not been performed in children, and the advisability of undertaking pediatric FTx is contested (17, 18). While FTx in adults is less controversial than in pediatric populations, the adult population itself is composed of subgroups with distinct developmental and psychosocial profiles. In this Perspective, we seek to characterize implications of FTx for emerging adults, defined as adults ages 18–25 years old, to inform decision-support needs and strategies to promote optimal outcomes for this distinct population. Drawing on our clinical experience and the literature at the intersection of transplant medicine, developmental psychology, and ethics, we synthesize and apply the existing evidence and suggest preliminary strategies to better support this heretofore understudied group.

2 Purpose of FTx: improving quality of life and social integration

FTx is not considered to be a lifesaving surgery in the way that solid organ transplantation (SOT) is generally classified. Patients in need of FTx are not at risk of imminent death, as may be the case for someone in need of a heart or liver transplant. That said, critics have argued that the procedure may still be considered crucial for a patient's quality of life, social integration and wellbeing. FTx has the potential to prevent, or even reverse, the loss of social connection that often accompanies profound facial disfigurement, termed “social death” by scholars in this space (19). Social death encapsulates the sense of isolation, ostracism, and loss of identity felt by many people living with severe facial disfigurement.

While FTx offers significant potential psychosocial benefits related to reduction in social stigma, it is also important to consider the procedure's functional benefits. FTx candidates often present with deficits in their ability to smell, breathe, speak, and experience facial sensation (20). Following FTx, patients report marked improvements in these areas of function. Furthermore, many FTx recipients may achieve independence from life-supporting measures such as tracheostomy and gastrostomy tubes. FTx is also remarkable in its ability to improve speech quality. Many patients with speech deficits are able to regain intelligible speech within a year of transplantation, a key component of social integration (20). The potential of FTx to facilitate social reintegration and ameliorate other significant functional challenges is particularly meaningful when considering FTx in emerging adulthood. Indeed, emerging adulthood's outsized significance in shaping life trajectory may make FTx particularly beneficial for this age group.

3 Emerging adults as a distinct population in FTx

3.1 Emerging identity and independence

Why consider defining emerging adults as a separate population in the context of FTx? Emerging adulthood encompasses individuals in the range of 18–25 years old. Although emerging adults share traits with adolescents and adults, developmental psychology has come to view this population as a distinct group based on the work of Jeffrey Arnett, who is credited with developing the term in 2000 (21). The basis for this distinction is attributed to the fact that emerging adults have not yet assumed many of the responsibilities of typical adulthood but have largely moved beyond the restrictive social structures and oversight of adolescence. As a result, emerging adults are capable of exploring their identities with a freedom and independence that is generally not possible at other stages of life (21). In previous decades, the distinction between emerging adults and young adults may have seemed trivial. However, the psychosocial factors precipitating the emergence of this new group—particularly in industrialized and technology centered societies—have become more pronounced in recent years.

Marriage, family life, and career building are traditionally thought to be the defining steps in the transition from adolescence to adulthood (22). Yet young people in the United States are marrying at later ages (23). Furthermore, from 1970 to 2014, the average maternal age at first childbirth rose from 21.4 years to 26.3 years and the average paternal age at first childbirth rose from 27.4 years to 30.9 years (24). As 18–25-year-olds are settling into the typical roles of adulthood later in life, this shift in responsibility and attitude has opened new opportunities for this age group. Having left the dependency of childhood and adolescence, emerging adults find themselves at a position in life with an extraordinarily broad scope of possibilities—most notably in the domains of romantic attachments, establishment of livelihood, and the formation of their worldviews (21). This window of opportunity becomes especially relevant when treating emerging adults in a medical setting. A condition such as sudden, profound facial disfigurement, may severely limit these areas of opportunity during a critical formative window. Consideration of the psychosocial makeup of this group is paramount to ensuring the support emerging adults may need when receiving medical care.

3.2 Developing cognition

Arnett's conceptual designation of emerging adulthood as a specific developmental phase has gained widespread traction in developmental psychology and is further supported by advances in cognitive neuroscience (25–27). For example, risk taking behavior in emerging adults results in a markedly higher mortality risk when compared to other populations. This likely reflects a combination of emerging adults' freedom and their incomplete brain maturity (28). It is well known that the prefrontal cortex serves as the nidus for executive function, allowing for abilities such as planning, abstract thinking, emotional control, and coping with stress (29). However, the growth of brain structures does not occur simultaneously. While the prefrontal cortex generally matures into the mid- to late 20s, growth of the reward-driven striatum, medial, and orbital prefrontal cortices occurs earlier than the regions responsible for cognitive control. The resultant discrepancy as explained by the, “dual-system model,” is often cited as a source of the higher rates of impulsivity, sensation seeking, and risky decision-making that characterizes young and emerging adulthood (30). While emerging adults are by no means incapable of making difficult and nuanced decisions, considering their developmental stage is important when evaluating the ethical ramifications of a life-altering procedure such as FTx, since the procedure carries long-term risks which may be harder for an emerging adult who has not reached full cognitive maturity to understand, appreciate, and integrate into their decision-making process.

3.3 Insights from SOT

Surgical areas such as SOT can provide valuable insights into the particular support needs this patient population may experience. As in FTx, the success of SOT relies on long-term adherence to immunosuppressive medication. For kidney transplants, older adolescents and young adults (a cohort defined as 17–24 year olds), irrespective of the age at transplant, were found to have the highest risk of graft failure (28). The consequences of nonadherence and its associated risk of graft failure have the potential to reduce life expectancy, opportunities for repeat transplantation, and success in work and school (31). Factors influencing nonadherence in SOT are broad, but most are rooted in the fact that regions of the brain mature on differing timelines (32–34).

Medication adherence is an important issue in FTx and research from SOT is valuable for understanding this dimension of risk in FTx. However, the indications and outcomes for FTx differ substantially from SOT. As an externally visible procedure with significant aesthetic as well as functional indications, FTx involves ethical and psychosocial issues beyond the scope of SOT. In this sense, FTx closely aligns with reconstructive plastic surgery procedures treating other forms of facial disfigurement. In general, congenital disfigurements are more likely to have improved outcomes when corrected during childhood and adolescence (35–37). Although not typically performed in emerging adults, the early age at which these reconstructive surgeries typically take place reflects a desire not only to restore function but also to address and hopefully mitigate psychosocial disadvantages and biases that individuals with significant visible facial differences may experience across the life course.

3.4 Implications for informed consent

Fully informed consent reflects an ongoing process of shared decision making between the surgical team and the patient (38, 39). Emerging adults are legally considered adults capable of providing informed consent, which differentiates them from adolescent and younger pediatric populations. Advances in neuroscience suggest that cognitive development continues through the mid-twenties, and the rate at which emerging adults mature cognitively during this time period varies between individuals (40, 41). Care should be taken to ensure that emerging adult FTx candidates are fully informed and demonstrate the judgement needed to make reasonable decisions about short and long-term risks and requirements of the procedure, particularly given the lifelong nature of follow up needed to maintain a functioning graft. Recognizing that emerging adulthood is still a time of flux for the maturing brain provides an opportunity for care teams to tailor the consent process to better promote optimal outcomes within this population.

3.5 Fully understanding risks of morbidity and mortality in FTx

Following FTx, immunosuppressive medication is essential to the maintenance of the graft. Emerging adults are at a heightened risk of struggling to adhere to medication regimens. For the first time in their lives, many emerging adults are living outside of the scrutiny of parental oversight and social structures such as school. Unlike in SOT, where retransplantation is not uncommon, retransplantation in FTx is rare. To date, only two facial retransplantations have been performed, both of which were in individuals past their 40s (42, 43). Such data further underscores the importance of medication adherence. The threat of irreplaceable graft failure is a serious consideration in FTx.

Immunosuppressive medications needed to maintain graft function carry their own serious risk profile, and FTx teams must strike a fine balance between under and over-immunosuppression. With too little immunosuppression, patients are at risk of losing the graft. With too much immunosuppression, the probability of opportunistic bacterial, fungal, and protozoal infection all increase (44–46). Furthermore, posttransplant malignancies are well known potential consequences of lifelong immunosuppression. While strategies have been developed to reduce the nonimmunologic risks associated with immunosuppressive medications, immunosuppressive medications are accompanied by a host of potential deleterious effects on cardiovascular, renal, endocrine, gastrointestinal, and musculoskeletal health, including organ toxicity (47–52). While established adults must also accept the risks associated with immunosuppressive medication, the earlier age at which EAs receive their graft means greater lifetime exposure to the harmful effects of the medications.

Ultimately, the toxicity of long-term immunosuppressive medication may lead to irreversible damage resulting in death; the real possibility of a shortened lifespan looms, particularly for emerging adults who are otherwise in good health and would have a typical lifespan ahead of them. Furthermore, emerging adults usually have little if any experience making a decision to pursue a life-altering procedure with possible risk of mortality. They are at a life stage where they are likely still developing their thoughts on death and dying (53). Thus, they may be undertaking a procedure where a full understanding of the existential consequences may only be apparent with hindsight. The chance of post-operative regret is possible, and special care must be taken in this population to ensure that they have a thorough understanding of the long-term complications of FTx. Indeed, the capacity to fully understand the long term consequences of one's actions is crucial to the consenting process when undertaking major medical procedures, especially for those, such as FTx, that are considered elective (54). This is a major consideration when taking into account the greater likelihood of a shortened lifespan with FTx (2).

3.6 Beyond functional benefits: milestones and identity formation

FTx recipients report marked improvements in function. The functional gains of the procedure work synergistically with the aesthetic benefits to enhance FTx recipients' social integration in a number of domains. Focusing on the framework of emerging adulthood, particularly the significance of this stage in reaching milestones in romantic attachment, livelihood, and worldviews, it is not surprising that FTx offers benefits in social integration and personal development. While FTx can be a life-altering event for established adults, their progression through social milestones places them in a position of relative stability compared to a younger person, for whom choices about livelihood or romantic partnering remain more open and subject to change.

Identity exploration is one of, if not the most, important drivers for the consideration of FTx in emerging adults. In largely individualistic, Western contexts, the beginning of the search for a sense of self results from a combination of (a) increased mental capacities to consider multiple possibilities and (b) a social context where multiple alternatives are available and from which one or more may be selected (55). The active consideration of identity alternatives is assumed to subside once one has enacted firm adult commitments (however “adult commitments” are defined in the society where one lives) and has entered into adult roles such as permanent partnership, employment, and parenthood (56).

Leaving adolescence, emerging adults find themselves in a social context where multiple opportunities exist for the direction of their lives. Crucially, they now possess the mental capacity to rationally consider such opportunities (57). Identity formation is a lifelong process, but the latitude of freedom enjoyed by emerging adults affords them the chance to make choices with uniquely profound consequences on their inner and outer lives. A robust social context and support system is essential during this window of opportunity (58). The possibility of social reintegration is perhaps the greatest benefit FTx can offer emerging adults during a key phase. In facilitating a greater sense of social integration, FTx affords emerging adults the opportunity to experiment with and solidify their identities in areas such as sexuality and physical intimacy, religion, life philosophy, and career choice (59).

4 Tailoring approaches to meet support needs

Engaging emerging adults in a robust shared decision-making process is essential, with particular attention to understanding short- and long-term risks and benefits, including challenges with adherence and the limits of current knowledge. Peer-recipient counseling and comprehension techniques such as the teach-back method have already been demonstrated to be effective in other areas surgery and transplantation (60, 61). Applying such techniques in tandem with adherence support planning and long-term mental health, employment, and social reintegration follow up has the potential to promote wellbeing and improve outcomes in emerging adult FTx recipients (13, 62–64).

5 Conclusion

FTx is a highly innovative procedure requiring rigorous rehabilitation and a lifelong commitment to follow up care for recipients. Occupying space at the forefront of innovative medicine, significant resources are dedicated to each FTx and special care is given to monitoring and supporting the success of FTx recipients. Emerging adults, whose identities are still evolving, may benefit in particular from the social reintegration FTx can facilitate, yet this life phase also introduces challenges for judgement and long-term adherence. Given the complexity of FTx and lifelong commitment to follow up required for FTx recipients, it is critical to understand issues for decision-making and obstacles to adherence that individuals may face in this developmental life stage. Surgical teams should be aware of the psychosocial factors that may influence their patients' motivations and decision-making processes, and attendant ethical implications for pre- and post-transplant evaluation and support. Emerging adulthood is a transformative period, and FTx during these years has the potential to be a profoundly life-altering experience.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Footnotes

Edited by: Martin Kumnig, Innsbruck Medical University, Austria

Reviewed by: Felix J. Klimitz Yale University, United States

Statements

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Funding

The author(s) declared that financial support was not received for this work and/or its publication.

Data availability

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Author contributions

MM: Writing – review & editing, Writing – original draft, Formal analysis, Conceptualization, Data curation, Investigation. HW: Writing – review & editing, Writing – original draft. AG: Writing – original draft, Writing – review & editing. ER: Writing – review & editing, Writing – original draft. LK: Resources, Validation, Writing – review & editing, Project administration, Methodology, Writing – original draft, Conceptualization, Supervision.

References

  1. 1. Rahmel A. Vascularized composite allografts: procurement, allocation, and implementation. Curr Transplant Rep. (2014) 1 (3): 173 – 82. doi:10.1007/s40472-014-0025-6
  2. 2. National Academies of Sciences E, Medicine. Advancing Face and Hand Transplantation: Principles and Framework for Developing Standardized Protocols. In: Kizer KW, Cooper R, editors. Washington, DC: The National Academies Press (2025). p. 388.
  3. 3. Mazziotta J. Man undergoes World's first successful face & double hand transplant. People Magazine. (2021) /02/02.
  4. 4. Connors J. The story of a face. Natl Geogr Mag. (2018) 234.
  5. 5. Moshtaghian A. Connie Culp, the first person to receive a near-total face transplant in the US, has died. CNN. (2020).
  6. 6. Hunter M. World's third full face transplant patient says operation ‘best decision I ever made '. The Independent. (2022).
  7. 7. Devauchelle B, Badet L, Lengelé B, Morelon E, Testelin S, Michallet M. First human face allograft: early report. Lancet. (2006) 368 (9531): 203 – 9. doi:10.1016/S0140-6736(06)68935-6
  8. 8. Homsy P, Huelsboemer L, Barret JP, Blondeel P, Borsuk DE, Bula D. An update on the survival of the first 50 face transplants worldwide. JAMA Surg. (2024) 159 (12): 1339. doi:10.1001/jamasurg.2024.3748
  9. 9. Ceradini DJ, Tran DL, Dedania VS, Gelb BE, Cohen OD, Flores RL. Combined whole eye and face transplant: microsurgical strategy and 1-year clinical course. Jama. (2024) 332 (18): 1551 – 8. doi:10.1001/jama.2024.12601
  10. 10. Pribaz JJ, Caterson EJ. Evolution and limitations of conventional autologous reconstruction of the head and neck. J Craniofac Surg. (2013) 24 (1): 99 – 107. doi:10.1097/SCS.0b013e31827104ab
  11. 11. Khalifian S, Brazio PS, Mohan R, Shaffer C, Brandacher G, Barth RN. Facial transplantation: the first 9 years. Lancet. (2014) 384 (9960): 2153 – 63. doi:10.1016/S0140-6736(13)62632-X
  12. 12. Tchiloemba B, Kauke M, Haug V, Abdulrazzak O, Safi AF, Kollar B. Long-term outcomes after facial allotransplantation: systematic review of the literature. Transplantation. (2021) 105 (8): 1869 - 1880. doi:10.1097/TP.0000000000003513
  13. 13. Blankenstein AP, Osborn SH, Aguilar NN, Manzo MC, Bailey B, Zacharek A. Psychological outcomes of facial transplantation: a systematic review of depression and mental health–related quality of life. Ann Plast Surg. (2025) 10: 1097. doi:10.1097/SAP.0000000000004487
  14. 14. Huelsboemer L, Kauke-Navarro M, Boroumand S, Parikh N, Hosseini H, Yu CT. Ten-year follow-up after face transplantation—a single-center retrospective cohort study. Am J Transplant. (2025) 25 (3): 611 – 22. doi:10.1016/j.ajt.2024.10.007
  15. 15. Keener AB. Saving face: the search for alternatives to life-long immunosuppression for face transplants. Nat Med. (2016) 22 (5): 448 – 9. doi:10.1038/nm0516-448
  16. 16. Kantar RS, Alfonso AR, Diep GK, Berman ZP, Rifkin WJ, Diaz-Siso JR. Facial transplantation: principles and evolving concepts. Plast Reconstr Surg. (2021) 147 (6): 1022e - 1038e. doi:10.1097/PRS.0000000000007932
  17. 17. Marchac A, Kuschner T, Paris J, Picard A, Vazquez MP, Lantieri L. Ethical issues in pediatric face transplantation: should we perform face transplantation in children? Plast Reconstr Surg. (2016) 138 (2): 449 – 54. doi:10.1097/PRS.0000000000002387
  18. 18. Laspro M, Thys E, Stead T, Onu OC, Rodriguez ED, Kimberly LL. Forthcoming.
  19. 19. Bramstedt KA. A lifesaving view of vascularized composite allotransplantation. J Patient Exp. (2018) 5 (2): 92 – 100. doi:10.1177/2374373517730556
  20. 20. Fischer S, Kueckelhaus M, Pauzenberger R, Bueno EM, Pomahac B. Functional outcomes of face transplantation. Am J Transplant. (2015) 15 (1): 220 – 33. doi:10.1111/ajt.12956
  21. 21. Arnett JJ. Emerging adulthood: a theory of development from the late teens through the twenties. Am Psychol. (2000) 55 (5): 469 – 80. doi:10.1037/0003-066X.55.5.469
  22. 22. Smock PJ, Schwartz CR. The demography of families: a review of patterns and change. J Marriage Fam. (2020) 82 (1): 9 – 34. doi:10.1111/jomf.12612
  23. 23. Bloome D, Ang S. Marriage and union formation in the United States: recent trends across racial groups and economic backgrounds. Demography. (2020) 57 (5): 1753 – 86. doi:10.1007/s13524-020-00910-7
  24. 24. Shadyab AH, Manson JE, Li W, Gass M, Brunner RL, Naughton MJ. Associations of parental ages at childbirth with healthy aging among women. Maturitas. (2019) 129: 6 – 11. doi:10.1016/j.maturitas.2019.08.002
  25. 25. Lozano Wun V, Klein SD, Collins PF, Luciana M. Within-person imbalance of reward sensitivity and executive functioning across adolescent development: a longitudinal examination of the dual systems model from childhood to adulthood. Dev Psychol. (2025) 61: 2375 – 95. doi:10.1037/dev0001969
  26. 26. Shulman EP, Smith AR, Silva K, Icenogle G, Duell N, Chein J. The dual systems model: review, reappraisal, and reaffirmation. Dev Cogn Neurosci. (2016) 17: 103 – 17. doi:10.1016/j.dcn.2015.12.010
  27. 27. Grydeland H, Vértes PE, Váša F, Romero-Garcia R, Whitaker K, Alexander-Bloch AF. Waves of maturation and senescence in micro-structural MRI markers of human cortical myelination over the lifespan. Cerebral cortex. (2019) 29 (3): 1369 – 81. doi:10.1093/cercor/bhy330
  28. 28. Foster BJ, Dahhou M, Zhang X, Platt RW, Samuel SM, Hanley JA. Association between age and graft failure rates in young kidney transplant recipients. Transplantation. (2011) 92 (11): 1237 – 43. doi:10.1097/TP.0b013e31823411d7
  29. 29. Kolk SM, Rakic P. Development of prefrontal cortex. Neuropsychopharmacology. (2022) 47 (1): 41 – 57. doi:10.1038/s41386-021-01137-9
  30. 30. Kray J, Schmitt H, Lorenz C, Ferdinand NK. The influence of different kinds of incentives on decision-making and cognitive control in adolescent development: a review of behavioral and neuroscientific studies. Front Psychol. (2018) 9: 768. doi:10.3389/fpsyg.2018.00768
  31. 31. Hariharan S, Israni AK, Danovitch G. Long-term survival after kidney transplantation. N Engl J Med. (2021) 385 (8): 729 – 43. doi:10.1056/NEJMra2014530
  32. 32. Casey BJ, Jones RM, Hare TA. The adolescent brain. Ann N Y Acad Sci. (2008) 1124 (1): 111 – 26. doi:10.1196/annals.1440.010
  33. 33. Vittorio J, Kosmach-Park B, King LY, Fischer R, Fredericks EM, Ng VL. Health care transition for adolescents and young adults with pediatric-onset liver disease and transplantation. J Pediatr Gastroenterol Nutr. (2023) 76 (1): 84 – 101. doi:10.1097/MPG.0000000000003560
  34. 34. Cousino MK, Schumacher KR, Rea KE, Eder S, Zamberlan M, Jordan J. Psychosocial functioning in pediatric heart transplant recipients and their families. Pediatr Transplant. (2018) 22 (2): e13110. doi:10.1111/petr.13110
  35. 35. Wlodarczyk JR, Wolfswinkel EM, Liu A, Fahradyan A, Higuchi E, Goel P. Early cleft lip repair: demonstrating efficacy in the first 100 patients. Plast Reconstr Surg. (2022) 150 (5): 1073 – 80. doi:10.1097/PRS.0000000000009634
  36. 36. Di Rocco F, Proctor MR. Technical evolution of pediatric neurosurgery: craniosynostosis from 1972 to 2023 and beyond. Childs Nerv Syst. (2023) 39 (10): 2779 – 87. doi:10.1007/s00381-023-06113-w
  37. 37. Dias MS, Samson T, Rizk EB, Governale LS, Richtsmeier JT. Identifying the misshapen head: craniosynostosis and related disorders. Pediatrics. (2020) 146 (3): e2020015511. doi:10.1542/peds.2020-015511
  38. 38. Loeff DS, Shakhsheer BA. The ethics of informed consent and shared decision-making in pediatric surgery. Semin Pediatr Surg. (2021) 30 (5): 151101. doi:10.1016/j.sempedsurg.2021.151101
  39. 39. Slim K, Bazin JE. From informed consent to shared decision-making in surgery. J Visc Surg. (2019) 156 (3): 181 – 4. doi:10.1016/j.jviscsurg.2019.04.014
  40. 40. Davey CG, Fornito A, Pujol J, Breakspear M, Schmaal L, Harrison BJ. Neurodevelopmental correlates of the emerging adult self. Dev Cogn Neurosci. (2019) 36: 100626. doi:10.1016/j.dcn.2019.100626
  41. 41. Silvers JA, Peris TS. Research review: the neuroscience of emerging adulthood—reward, ambiguity, and social support as building blocks of mental health. J Child Psychol Psychiatry. (2023) 64 (7): 989 – 97. doi:10.1111/jcpp.13776
  42. 42. Lantieri L, Cholley B, Lemogne C, Guillemain R, Ortonne N, Grimbert P. First human facial retransplantation: 30-month follow-up. Lancet. (2020) 396 (10264): 1758 – 65. doi:10.1016/S0140-6736(20)32438-7
  43. 43. Kauke M, Panayi AC, Safi AF, Haug V, Perry B, Kollar B. Full facial retransplantation in a female patient—technical, immunologic, and clinical considerations. Am J Transplant. (2021) 21 (10): 3472 – 80. doi:10.1111/ajt.16696
  44. 44. Van Delden C, Stampf S, Hirsch HH, Manuel O, Meylan P, Cusini A. Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss transplant cohort study. Clin Infect Dis. (2020) 71 (7): e159 – e69. doi:10.1093/cid/ciz1113
  45. 45. Roberts MB, Fishman JA. Immunosuppressive agents and infectious risk in transplantation: managing the “net state of immunosuppression”. Clin Infect Dis. (2021) 73 (7): e1302 – e17. doi:10.1093/cid/ciaa1189
  46. 46. Szumilas K, Wilk A, Wiśniewski P, Gimpel A, Dziedziejko V, Kipp M. Current status regarding immunosuppressive treatment in patients after renal transplantation. Int J Mol Sci. (2023) 24 (12): 10301. doi:10.3390/ijms241210301
  47. 47. Vasilic D, Alloway RR, Barker JH, Furr A, Ashcroft R, Banis JCJ. Risk assessment of immunosuppressive therapy in facial transplantation. Plast Reconstr Surg. (2007) 120 (3): 657 – 68. doi:10.1097/01.prs.0000270316.33293.ec
  48. 48. Chauhan K, Khan A, Chowdhury S, Ross HM, Parra NS, Halegoua-DeMarzio D. A comprehensive review on the risk of metabolic syndrome and cardiovascular disease after liver transplantation. Livers. (2022) 2 (2): 85 – 96. doi:10.3390/livers2020006
  49. 49. Diker Cohen T, Dotan I, Calvarysky B, Robenshtok E. Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients. Eur J Endocrinol. (2025) 193 (3): R1 – R16. doi:10.1093/ejendo/lvaf182
  50. 50. Russo MW, Wheless W, Vrochides D. Management of long-term complications from immunosuppression. Liver Transpl. (2024) 30 (6): 647 – 58. doi:10.1097/LVT.0000000000000341
  51. 51. Sarabhai T, Mathew A, Rashidi-Alavijeh J, Willuweit K, Gallinat A, Führer D. Diabetes Mellitus and osteoporosis after organ transplantation: frequency, clinical features, and treatment. Dtsch Arztebl Int. (2026) (Forthcoming): arztebl.m2026.0019. doi:10.3238/arztebl.m2026.0019
  52. 52. Jin F, Vajdic CM, Poynten IM, McGee-Avila JK, Castle PE, Grulich AE. Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis. Lancet Oncol. (2024) 25 (7): 933 – 44. doi:10.1016/S1470-2045(24)00189-X
  53. 53. Arnett JJ, Žukauskienė R, Sugimura K. The new life stage of emerging adulthood at ages 18–29 years: implications for mental health. Lancet Psychiatry. (2014) 1 (7): 569 – 76. doi:10.1016/S2215-0366(14)00080-7
  54. 54. Kumnig M, Jowsey-Gregoire SG. Key psychosocial challenges in vascularized composite allotransplantation. World J Transplant. (2016) 6 (1): 91 – 102. doi:10.5500/wjt.v6.i1.91
  55. 55. Bosma HA, Kunnen ES. Determinants and mechanisms in ego identity development: a review and synthesis. Dev Rev. (2001) 21 (1): 39 – 66. doi:10.1006/drev.2000.0514
  56. 56. Luyckx K, Schwartz SJ, Goossens L, Pollock S. Employment, sense of coherence, and identity formation: contextual and psychological processes on the pathway to sense of adulthood. J Adolesc Res. (2008) 23 (5): 566 – 91. doi:10.1177/0743558408322146
  57. 57. Schwartz SJ, Zamboanga BL, Luyckx K, Meca A, Ritchie RA. Identity in emerging adulthood:reviewing the field and looking forward. Emerg Adulthood. (2013) 1 (2): 96 – 113. doi:10.1177/2167696813479781
  58. 58. Scardera S, Perret LC, Ouellet-Morin I, Gariépy G, Juster RP, Boivin M. Association of social support during adolescence with depression, anxiety, and suicidal ideation in young adults. JAMA Netw. Open. (2020) 3 (12): e2027491. doi:10.1001/jamanetworkopen.2020.27491
  59. 59. Schwartz SJ, Donnellan MB, Ravert RD, Luyckx K, Zamboanga BL. Identity development, personality, and well-being in adolescence and emerging adulthood: theory, research, and recent advances. Handbook of Psychology, Second Edition. (2012): 6. doi:10.3238/arztebl.m2026.0019
  60. 60. Fink AS, Prochazka AV, Henderson WG, Bartenfeld D, Nyirenda C, Webb A. Enhancement of surgical informed consent by addition of repeat back: a multicenter, randomized controlled clinical trial. Ann Surg. (2010) 252 (1): 27 – 36. doi:10.1097/SLA.0b013e3181e3ec61
  61. 61. Gordon EJ, Reddy E, Ladner DP, Friedewald J, Abecassis MM, Ison MG. Kidney transplant candidates' Understanding of increased risk donor kidneys: a qualitative study. Clin Transplant. (2012) 26 (2): 359 – 68. doi:10.1111/j.1399-0012.2011.01536.x
  62. 62. Hummel NR, Zuo KJ, Talbot S, Zimmerman ZE, Katz JN, Kinsley SE. Psychosocial predictors in upper-extremity vascularized composite allotransplantation: a qualitative study of multidimensional experiences including patients, healthcare professionals, and close relatives. Front Psychol. (2023) 14: 1092725. doi:10.3389/fpsyg.2023.1092725
  63. 63. Jowsey-Gregoire SG, Kumnig M, Morelon E, Moreno E, Petruzzo P, Seulin C. The chauvet 2014 meeting report: psychiatric and psychosocial evaluation and outcomes of upper extremity grafted patients. Transplantation. (2016) 100 (7): 1453 – 9. doi:10.1097/TP.0000000000001013
  64. 64. Myaskovsky L, Jesse MT, Kuntz K, Leino AD, Peipert JD, Russell CL. Report from the American society of transplantation psychosocial community of practice adherence task force: real-world options for promoting adherence in adult recipients. Clin Transplant. (2018) 32 (9): e13353. doi:10.1111/ctr.13353

Citation

McKenna, M. E., et al. (2026). Facial transplantation in emerging adulthood: characterizing challenges and opportunities to support optimal outcomes. Frontiers in Transplantation, Volume 5. https://doi.org/
Received
Accepted
Published
Volume
5 - 2026

Copyright

© 2026 McKenna, Wyatt, Gursky, Rodriguez and Kimberly.

License: https://creativecommons.org/licenses/by/4.0/

*Correspondence: Laura L. Kimberly

Article metrics

Views
0
Downloads
0
Citations
0
Shares
0